Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Feb 28, 2006 by Edgar Snyder

Date Set for First Celebrex Trial

Celebrex Trail

The first trial over Pfizer’s Celebrex is set to begin this June. The plaintiff, Rosie Ware, believes the pain reliever, Celebrex, caused her stroke in 2005.

Since Celebrex is still on the market, Ms. Ware’s attorneys may have a more difficult time proving the prescription drug caused her stroke. Vioxx and Bextra, both Cox-2 inhibitors like Celebrex, were taken off the market after serious cardiovascular events were linked to their use. The Food and Drug Administration (FDA) did require Celebrex to put a “black-box” warning on their label that emphasizes the drug may increase the risk of cardiovascular events.

Prior to her use of Celebrex, Ms. Ware was in good health and was taking the pain reliever for a back problem. After suffering a stroke, she was left disabled and unable to work.

Currently, the FDA feels the benefits of Celebrex still outweigh its risks.

For more information about dangerous or recalled drugs, visit our Recalled and Dangerous Drug Legal Center.

Drug litigation may involve co-counsel.

Source: “First Celebrex Trial Date is Set.” By Heather Won Tesoriero. The Wall Street Journal. February 28, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers